Demyelination in rheumatic diseases

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 3, 2006, Pages 290-295

  Theodoridou, Athina ^a   Settas, L ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; BEHCET DISEASE; CENTRAL NERVOUS SYSTEM; CHRONIC INFLAMMATION; CLINICAL FEATURE; DEMYELINATION; HUMAN; MULTIPLE SCLEROSIS; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; SJOEGREN SYNDROME; SPINAL CORD; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; WHITE MATTER;

EID: 33644551868     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2005.075861     Document Type: Review

References (78)

1. Ferreira S, D'Cruz DP, Hughes GRV. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) 2005;44(4):434-42.
2. Ruiz-Irastoza G, Khamashta MA. Warfarin for multiple sclerosis? Q J Med 2000;93:497-9.
3. Berman M, Feldman S, Alter M, et al. Acute transverse myelitis: incidence and etiologic considerations. Neurology 1981;31:966-71.
4. Cuadrado MJ, Khamashta MA, Ballesteros A, et al. Can neurologic manifestations of Hughes' (antiphospholipid) syndrome be distinguished from multiple sclerosis. Analysis of 27 patients and review of the literature. Medicine (Baltimore) 2000;79:57-68.
5. Hughes GRV. Migraine, memory loss, and "multiple sclerosis". Neurological features of the antiphospholipid (Hughes') syndrome. Postgrad Med J 2003;79:81-3.
6. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-7.
7. McLean BN, Luxton RW, Thompson EJ. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the log IgG-index. A comparison and diagnostic applications. Brain 1990;113(Pt 5):1269-89.
8. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
9. Bluestein HG. Neuropsychiatric disorders in systemic lupus erythematosus. In: Lahita RG, ed. Systemic lupus erythematosus. New York: Wiley, 1987:593-614.
10. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-69.
11. Arnold DL, Matthews PM. MRI in the diagnosis and management of multiple sclerosis. Neurology 2002;58(suppl 4):23-31.
12. Rovaris M, Viti B, Ciboddo G, et al. Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetization transfer imaging study. J Neurol Neurosurg Psychiatry 2000;68:170-7.
13. Alexander GE, Provost TT, Stevens MB, et al. Sjoegren's syndrome: central nervous system manifestations. Neurology 1981;31:1391-6.
14. Karussis D, Leker RR, Ashkenazi A, et al. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol 1998;44:629-34.
15. Roussel V, Yi F, Jauberteau MO, et al. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients. J Autoimmun 2000;14:259-65.
16. Penn AS, Rowan AJ. Myelopathy in systemic lupus erythematosus. Arch Neurol 1968;18:337-49.
17. Kovacs B, Lafferty TL, Brent LH, et al. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 2000;59:120-4.
18. Lavelle C, Pizarro S, Drenkard C, et al. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 1990;17:34-7.
19. Deodhar AA, Hochenedel T, Bennett RM. Longitudinal involvement of the entire spinal cord and the medulla oblongata in acute catastrophic onset transverse myelitis in SLED. J Rheumatol 1999;26:446-9.
20. Cordeiro MF, Lloyd ME, Spalton DJ, et al. Ischemic optic neuropathy, transverse myelitis and epilepsy in an antiphospholipid positive patient with systemic lupus erythematosus [letter]. J Neurol Neurosurg Psychiatry 1994;57:1142-3.
21. Schantz V, Oestergaard LL, Junker P. Shrinking spinal cord following transverse myelopathy in a patient with systemic lupus erythematosus and the phospholipids antibody syndrome. J Rheumatol 1998;25:1425-8.
22. Smyth AE, Bruce JN, McMillan SA, et al. Transverse myelitis: a complication of systemic lupus erythematosus that is associated with the antiphospholipid syndrome [abstract]. Ulster Med J 1996;65:91-4.
23. Kim JH, Lee SI, Park SI, et al. Recurrent transverse myelitis in primary antiphospholipid syndrome-case report and literature review. Rheumatol Int 2004;24:244-6.
24. Medina-Rodriquez F, Garcia E, Fraga A. Transverse myelitis and antiphospholipid antibodies. J Rheumatol 1990;17(1):34-7.
25. Provenzale JM, Barboriak DP, Gaensler EH, et al. Lupus-related myelitis: serial MR findings. Am J Neuroradiol 1994;15:1911-7.
26. April RS, Vansonnenberg E. A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus. Neurology 1976;26:1066-70.
27. Kenik JG, Krohn K, Kelly RB, et al. Transverse myelitis and optic neuritis in systemic lupus erythematosus: a case report with magnetic resonance imaging findings. Arthritis Rheum 1987;30:947-50.
28. Tola MR, Casetta J, Granieri E, et al. Systemic lupus erythematosus related transverse myelitis in a patient with myasthenia gravis and multiple sclerosis. Eur Neurol 1996;36:327-8.
29. Harisdangkul V, Doorenbos D, Subramony SH. Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol 1995;242:326-31.
30. Noseworthy JH, Bass BH, Vandervoort MK, et al. The prevalence of primary Sjoegren's syndrome in a multiple sclerosis population. Ann Neurol 1989;25:95-8.
31. Sherer Y, Hassin S, Shoenfeld Y, et al. Transverse myelitis in patients with antiphospholipid antibodies-the importance of early diagnosis and treatment. Clin Rheumatol 2002;21:207-10.
32. Gibbs AN, Moroney J, Foley-Nolan D, et al. Neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: a case report. Rheumatology 2002;41:470-1.
33. Giorgi D, Balacco Gabrieli C. Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis. Clin Rheumatol 1999;18:124-31.
34. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-14.
35. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology 2002;41:619-30.
36. Jabs DA, Miller NR, Newman SA, et al. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol 1986;104:564-8.
37. Galindo-Rodriguez G, Avina-Zubieta JA, Pizarro S, et al. Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial. Am J Med 1999;106:65-9.
38. Scott TF, Hess D, Brillman J. Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging. Arch Intern Med 1994;154:917-20.
39. Ijdo JW, Conti-Kelly AM, Greco P, et al. Antiphospholipid antibodies in patients with multiple sclerosis and MS-like illness: MS or APS? Lupus 1999;8:109-15.
40. Marullo S, Clauvel JP, Intrator L, et al. Lupoid sclerosis with antiphospholipid and antimyelin antibodies. J Rheumatol 1993;20:747-9.
41. Rombos A, Evangelopoulou-Katsiri E, Leventakou A, et al. Serum IgG and IgM anticardiolipin antibodies in neurological diseases. Acta Neurol Scand 1990;81:43-5.
42. Sastre-Garriga J, Reverter JC, Font J, et al. Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis. Ann Neurol 2001;49:408-11.
43. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002;46:1019-27.
44. Lee DM, Jeon HS, Yoo WH. Transverse myelitis in a patient with primary antiphospholipid syndrome. Yonsei Med J 2003;44(2):323-7.
45. Shaharao V, Bartakke S, Muranjan MN, et al. Recurrent acute transverse myelopathy: association with antiphospholipid antibody syndrome. Indian J Pediatr 2004;71(6):559-61.
46. Inslicht DV, Stein AB, Pomerantz F, et al. Three women with lupus transverse myelitis: case reports and differential diagnosis. Arch Phys Med Rehabil 1998;79:456-9.
47. Andrianakos AA, Duffy J, Suzuki J, et al. Transverse myelopathy in systemic lupus erythematosus: report of three cases and review of the literature. Ann Intern Med 1975;83:616-24.
48. Kupersmith MJ, Burde R, Warren F, et al. Autoimmune optic neuropathy, evaluation and treatment. J Neurol Neurosurg Psychiatry 1988;51:1381-6.
49. Bielory L, Kupersmith MJ, Warren F, et al. Skin biopsies in the evaluation of atypical optic neuropathies. Ocul Immunol Inflamm 1993;1:231-41.
50. Frohman L, Turbin R, Bielory L, et al. Autoimmune optic neuropathy with anticardiolipin antibody mimicking multiple sclerosis in a child. Am J Ophthalmol 2003;136:358-60.
51. Alexander E. MS and Sjogren's syndrome. Neurology 1993;43:455-6.
52. Binder A, Snaith ML, lsenberg D. Sjoegren's syndrome: a study of its neurological complications. Br J Rheum 1988;27:275-80.
53. Andrianopoulos AP, Lagos G, Drosos AA, et al. Neurological involvement in primary Sjoegren's syndrome: a preliminary report. J Autoimmun 1989;2:485-8.
54. Mok CC, Lau CS, Chan EY, et al. Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. J Rheumatol 1998;25:467-73.
55. de Andres C, Guillem A, Rodriquez-Mahou M, et al. Frequency and significance of anti-Ro (SS-A) antibodies in multiple sclerosis patients. Acta Neurol Scand 2001;104:83-7.
56. Ioannidis JPA, Moutsopoulos HM. Sjoegren's syndrome: too many associations, too limited evidence. The enigmatic example of CNS involvement. Semin Arthritis Rheum 1999;29(1):1-3.
57. Jung SM, Lee BG, Joh GY, et al. Primary Sjoegren's syndrome manifested as multiple sclerosis and cutaneous erythematous lesions: a case report. J Korean Med Sci 2000;15:115-8.
58. Sandberg-Wollheim M, Axell T, Hansen BU, et al. Primary Sjoegren's syndrome in patients with multiple sclerosis. Neurology 1992;42:845-7.
59. Alexander EL, Beal SS, Gordon B, et al. Magnetic resonance imaging of cerebral lesions in patients with the Sjoegren's syndrome. Ann Intern Med 1988;108:815-23.
60. Alexander EL, Malinow K, Lejewski JE, et al. Primary Sjoegren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 1986;104:323-30.
61. Lafitte C, Amoura Z, Cacoub P, et al. Neurological complications of primary Sjoegren's syndrome. J Neurol 2001;248:557-84.
62. Tourbah A, Clapin A, Gout O, et al. Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study. Arch Neurol 1998;55:517-21.
63. Vincent TL, Richardson MP, Mackworth-Young CG, et al. Sjoegren's syndrome-associated myelopathy: response to immunosuppressive treatment. Am J Med 2003;114:145-8.
64. Wise CM, Agudelo CA. Optic neuropathy as an initial manifestation of Sjoegren's syndrome. J Rheumatol 1988;15(5):799-802.
65. Alexander EL, Provost TT, Stevens MB, et al. Neurologic complications of primary Sjoegren's syndrome. Medicine 1982;61:247-57.
66. Molina R, Provost TT, Alexander GE. Primary Sjoegren's syndrome. Arthritis Rheum 1985;28:1341-7.
67. Niemela RK, Hakala M. Primary Sioegren's syndrome with severe central nervous system disease. Semin Arthritis Rheum 1999;29(1):4-13.
68. Anantharaju A, Baluch M, Van Thiel DH. Transverse myelitis occurring in association with primary biliary cirrhosis and Sjoegren's syndrome. Dig Dis Sci 2003;48(4):830-3.
69. Wakatsuki T, Miyata M, Shishido S, et al. Sjoegren's syndrome with primary biliary cirrhosis, complicated by transverse myelitis and malignant lymphoma. Intern Med 2000;39:260-5.
70. Rutan G, Martinez AJ, Fieshko JT, et al. Primary biliary cirrhosis, Sjoegren's syndrome, and transverse myelitis. Gastroenterology 1986;90:206-10.
71. Sugai S. Sjoegren's syndrome associated with liver and neurological disorders, and malignant lymphoma. Intern Med 2000;39:193-4.
72. Williams C, Butler E, Roman GC. Treatment of myelopathy in Sjoegren's syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol 2001;58:815-19.
73. Akman-Demir G, Serdaroglu P, Tasci B, et al. Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. Brain 1999;122:2171-82.
74. Serdaroglu P. Behcet's disease and the nervous system. J Neurol 1998;245:197-205.
75. Tali ET, Atilla S, Keskin T, et al. MRI in neuro-Behcet's disease. Neuroradiology 1997;39:2-6.
76. Saruhan-Direskeneli G, Yentur SP, Akman-Demir G, et al. Cytokines and chemokines in neuro-Behcet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 2003;145:127-34.
77. Motomura S, Tabira T, Kuoiwa Y. A clinical comparative study of multiple sclerosis and neuro-Behcet's syndrome. J Neurol Neurosurg Psychiatry 1980;43:210-13.
78. Chavis PS, Tabbara KF. Demyelination of retinal myelinated nerve fibers in Behcet's disease. Doc Ophthalmol 1998;95:157-64.